Get More Information on mHealth Market - Request Sample Report
The mHealth Market size is expected to reach USD 142.94 Bn by 2031, and the base value of the market was valued at USD 62.93 Bn in 2023. The CAGR growth rate was recorded at 10.81% over the forecast period of 2024-2031.
Due to the extensive use of mobile devices and the rising demand for easily available and practical healthcare solutions, mHealth has seen a substantial increase in attention and popularity in recent years.
People can track and monitor a variety of health parameters, including heart rate, blood pressure, physical activity, sleep patterns, and more, using mobile apps and wearable technology. This information can offer perceptions into one's general health and assist people. Through mobile apps and wearable technology, healthcare professionals can remotely monitor patients with chronic diseases or those recovering from surgery. This lessens the need for numerous in-person visits and enables prompt intervention. Patients can consult with medical specialists via video calls, voice calls, or text messages thanks to mHealth. People who live in rural areas or have limited mobility would especially benefit from this. Mobile apps can deliver notifications for medication schedules, assisting patients in following their treatment plans and lowering the likelihood that they will forget to take their medications. Mobile apps give users access to medical knowledge, tools, and educational materials, enabling them to make well-informed decisions regarding their health.
Mobile devices can be used to swiftly contact emergency contacts or call for assistance in emergencies. First responders may find people in need with the help of location services. mHealth apps frequently utilise gamification and behavioural psychology tactics to encourage users to adopt better behaviours and lifestyles. Data analytics and research: Aggregated and anonymous data gathered by mHealth apps can support public health campaigns and medical research by revealing insights into illness patterns, the efficacy of treatments, and other topics. mHealth can assist in the management of certain diseases by providing pertinent data, tools, and resources for ailments including diabetes, asthma, and cardiovascular disorders.
Driver
The rise in use of mobile phones and technology in the emerging and the developed countries
A sizable section of the world's population can now access and use mHealth apps and services because to smartphones and other mobile device’s wide availability and low cost. The growth of mobile networks and the expanding accessibility of high-speed internet have made it possible for patients, healthcare professionals, and health systems to communicate with each other easily. Patient Empowerment: People are actively seeking tools and resources to actively manage their health and wellness as they become more involved in these areas. Through monitoring, tracking, and access to health information, mHealth apps enable people to take charge of their health.
Restrain
Privacy and Data Security:
Collecting, storing, and sharing sensitive health data are all part of the mHealth process. To retain patient confidence and adhere to laws like the HIPAA (Health Insurance Portability and Accountability Act), it is crucial to ensure the privacy and security of this data.
Opportunity
The rising investment and the rising initiatives.
Both major healthcare organisations and start-ups have invested in and innovated in response to the potential of mHealth, resulting in the creation of new technologies, apps, and services. Regulating agencies are adjusting to the changing world of digital healthcare, offering guidelines and frameworks to guarantee patient safety, data privacy, and the standard of care in mHealth services.
Challenge
For healthcare data and technology, different areas and nations have different laws and requirements. It can be difficult for mHealth app developers and healthcare providers to manoeuvre through these complicated regulatory settings.
Impact of Recession
People and families may put their essential requirements ahead of discretionary spending during hard economic times. This can cause mHealth apps that promote well-being, physical fitness, and other non-urgent health goals to lose users' interest and participation. Recessions may result in a rise in demand for telemedicine and other remote healthcare services. People may look for less expensive substitutes for in-person doctor appointments, and mHealth can offer a solution through remote monitoring and virtual consultations. Venture capital funding and investment in tech firms, particularly those in the mHealth industry, can sometimes be slowed down by economic downturns.
The operation of mHealth apps that depend on constant connectivity may be hampered if the conflict causes disruptions in infrastructure, such as telecommunication networks and internet services. This might have an effect on the use of mHealth tools, the transmission of health data, and remote consultations. Access to healthcare services: Due to infrastructure damage and population displacement, traditional healthcare services may not be available in conflict-affected areas. When people lack access to physical healthcare facilities, mHealth may be able to help by offering remote healthcare services and medical information. The ambiguity brought on by conflict and geopolitical tensions may result in decreased investment in the mHealth area of the technology industry. Innovation and venture capital funding in the mHealth sector.
Regional Analysis
mHealth solutions have been widely adopted in North America, especially in the United States and Canada. These consist of apps for tracking one's health, wearable medical technology, and telemedicine services. Strong technological foundations and increasing smartphone adoption are factors in the development of mHealth. Concerns about privacy and data security are significant challenges, and laws like HIPAA in the U.S. have an impact on the growth of mHealth.
Europe: The various healthcare systems and laws found in Europe cause different levels of mHealth adoption. Remote patient monitoring and telemedicine have gained popularity in nations including the UK, Germany, and the Netherlands. Considerations for data privacy in mHealth services are impacted by EU rules like GDPR. Europe has a variety of healthcare laws and institutions, which affects how widely mHealth is used. The UK, Germany, and the Netherlands are a few nations that have embraced
Asia-Pacific is a diverse region with varying levels of access to healthcare and technological infrastructure. Leading the way in the adoption of mHealth are nations like South Korea, Japan, and China. The adoption of mobile technology and innovation hubs support the expansion of mHealth. Popular mHealth tools include telemedicine and health monitoring applications, and in some situations, government initiatives encourage their use.
Get Customized Report as per Your Business Requirement - Request For Customized Report
The major players are AT&T, Telefonica, SoftServe, google, Samsung Electronics, Apple, Orange, mQure, Qualcomm Technologies, Vodafone Group and others.
AT & T: Boston scientific considers AT & T for mobile patient monitoring.
Telefonica: Telefonica and 3M optimise hospitals emergencies with AI.
| Report Attributes | Details |
| Market Size in 2023 | US$ 62.93 Bn |
| Market Size by 2031 | US$ 142.94 Bn |
| CAGR | CAGR of 10.81 % From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Component (Wearables, mHealth Apps) • By Participants (Mobile Participants, Device vendors, Content Players, Healthcare Providers) • By Services (Monitoring Services, Diagnosis Services, Healthcare Systems, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | AT &T, Telefonica, SoftServe, google, Samsung Electronics, Apple, Orange, mQure, Qualcomm Technologies, Vodafone Group |
| Key Drivers | • The rise in use of mobile phones and technology in the emerging and the developed countries |
| Market Restraints | • Privacy and Data Security |
Ans: The mHealth Market is expected to grow at a CAGR of 10.6 %.
Ans: The mHealth Market size is expected to reach USD 127 Bn by 2030, the base value of the market was valued at USD 56.8 Bn in 2022. The CAGR growth rate was recorded 10.6% over the forecast period of 2023-2030.
Ans: The rise in use of mobile phones and technology in the emerging and the developed countries
Ans: For healthcare data and technology, different areas and nations have different laws and requirements. It can be difficult for mHealth app developers and healthcare providers to manoeuvre through these complicated regulatory settings.
Ans: North America overtook other regional markets as the largest market for mHealth, with the highest revenue share.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of Russia-Ukraine War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. mHealth Market, By Component
8.1 Wearables
8.2 mHealth Apps
9. mHealth Market, By Participants
9.1Mobile Participants
9.2Device vendors
9.3Content Players
9.4Healthcare Providers
10. mHealth Market, By Services
10.1 Monitoring Services
10.2 Diagnosis Services
10.3 Healthcare Systems
10.4 Others
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America mHealth Market by Country
11.2.2 North America mHealth Market by Component
11.2.3 North America mHealth Market by Participants
11.2.4 North America mHealth Market by Services
11.2.5 USA
11.2.5.1 USA mHealth Market by Component
11.2.5.2 USA mHealth Market by Participants
11.2.5.3 USA mHealth Market by Services
11.2.6 Canada
11.2.6.1 Canada mHealth Market by Component
11.2.6.2 Canada mHealth Market by Participants
11.2.6.3 Canada mHealth Market by Services
11.2.7 Mexico
11.2.7.1 Mexico mHealth Market by Component
11.2.7.2 Mexico mHealth Market by Participants
11.2.7.3 Mexico mHealth Market by Services
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Eastern Europe mHealth Market by Country
11.3.1.2 Eastern Europe mHealth Market by Component
11.3.1.3 Eastern Europe mHealth Market by Participants
11.3.1.4 Eastern Europe mHealth Market by Services
11.3.1.5 Poland
11.3.1.5.1 Poland mHealth Market by Component
11.3.1.5.2 Poland mHealth Market by Participants
11.3.1.5.3 Poland mHealth Market by Services
11.3.1.6 Romania
11.3.1.6.1 Romania mHealth Market by Component
11.3.1.6.2 Romania mHealth Market by Participants
11.3.1.6.4 Romania mHealth Market by Services
11.3.1.7 Turkey
11.3.1.7.1 Turkey mHealth Market by Component
11.3.1.7.2 Turkey mHealth Market by Participants
11.3.1.7.3 Turkey mHealth Market by Services
11.3.1.8 Rest of Eastern Europe
11.3.1.8.1 Rest of Eastern Europe mHealth Market by Component
11.3.1.8.2 Rest of Eastern Europe mHealth Market by Participants
11.3.1.8.3 Rest of Eastern Europe mHealth Market by Services
11.3.2 Western Europe
11.3.2.1 Western Europe mHealth Market by Country
11.3.2.2 Western Europe mHealth Market by Component
11.3.2.3 Western Europe mHealth Market by Participants
11.3.2.4 Western Europe mHealth Market by Services
11.3.2.5 Germany
11.3.2.5.1 Germany mHealth Market by Component
11.3.2.5.2 Germany mHealth Market by Participants
11.3.2.5.3 Germany mHealth Market by Services
11.3.2.6 France
11.3.2.6.1 France mHealth Market by Component
11.3.2.6.2 France mHealth Market by Participants
11.3.2.6.3 France mHealth Market by Services
11.3.2.7 UK
11.3.2.7.1 UK mHealth Market by Component
11.3.2.7.2 UK mHealth Market by Participants
11.3.2.7.3 UK mHealth Market by Services
11.3.2.8 Italy
11.3.2.8.1 Italy mHealth Market by Component
11.3.2.8.2 Italy mHealth Market by Participants
11.3.2.8.3 Italy mHealth Market by Services
11.3.2.9 Spain
11.3.2.9.1 Spain mHealth Market by Component
11.3.2.9.2 Spain mHealth Market by Participants
11.3.2.9.3 Spain mHealth Market by Services
11.3.2.10 Netherlands
11.3.2.10.1 Netherlands mHealth Market by Component
11.3.2.10.2 Netherlands mHealth Market by Participants
11.3.2.10.3 Netherlands mHealth Market by Test Type
11.3.2.11 Switzerland
11.3.2.11.1 Switzerland mHealth Market by Component
11.3.2.11.2 Switzerland mHealth Market by Participants
11.3.2.11.3 Switzerland mHealth Market by Services
11.3.2.1.12 Austria
11.3.2.12.1 Austria mHealth Market by Component
11.3.2.12.2 Austria mHealth Market by Participants
11.3.2.12.3 Austria mHealth Market by Services
11.3.2.13 Rest of Western Europe
11.3.2.13.1 Rest of Western Europe mHealth Market by Component
11.3.2.13.2 Rest of Western Europe mHealth Market by Participants
11.3.2.13.3 Rest of Western Europe mHealth Market by Services
11.4 Asia-Pacific
11.4.1 Asia-Pacific mHealth Market by Country
11.4.2 Asia-Pacific mHealth Market by Component
11.4.3 Asia-Pacific mHealth Market by Participants
11.4.4 Asia-Pacific mHealth Market by Services
11.4.5 China
11.4.5.1 China mHealth Market by Component
11.4.5.2 China mHealth Market by Services
11.4.5.3 China mHealth Market by Participants
11.4.6 India
11.4.6.1 India mHealth Market by Component
11.4.6.2 India mHealth Market by Participants
11.4.6.3 India mHealth Market by Services
11.4.7 Japan
11.4.7.1 Japan mHealth Market by Component
11.4.7.2 Japan mHealth Market by Participants
11.4.7.3 Japan mHealth Market by Services
11.4.8 South Korea
11.4.8.1 South Korea mHealth Market by Component
11.4.8.2 South Korea mHealth Market by Participants
11.4.8.3 South Korea mHealth Market by Services
11.4.9 Vietnam
11.4.9.1 Vietnam mHealth Market by Component
11.4.9.2 Vietnam mHealth Market by Participants
11.4.9.3 Vietnam mHealth Market by Services
11.4.10 Singapore
11.4.10.1 Singapore mHealth Market by Component
11.4.10.2 Singapore mHealth Market by Participants
11.4.10.3 Singapore mHealth Market by Services
11.4.11 Australia
11.4.11.1 Australia mHealth Market by Component
11.4.11.2 Australia mHealth Market by Participants
11.4.11.3 Australia mHealth Market by Services
11.4.12 Rest of Asia-Pacific
11.4.12.1 Rest of Asia-Pacific mHealth Market by Component
11.4.12.2 Rest of Asia-Pacific mHealth Market by Participants
11.4.12.3 Rest of Asia-Pacific mHealth Market by Test Type
11.5 Middle East & Africa
11.5.1 Middle East
11.5.1.1 Middle East mHealth Market by Country
11.5.1.2 Middle East mHealth Market by Component
11.5.1.3 Middle East mHealth Market by Participants
11.5.1.4 Middle East mHealth Market by Services
11.5.1.5 UAE
11.5.1.5.1 UAE mHealth Market by Component
11.5.1.5.2 UAE mHealth Market by Participants
11.5.1.5.3 UAE mHealth Market by Services
11.5.1.6 Egypt
11.5.1.6.1 Egypt mHealth Market by Component
11.5.1.6.2 Egypt mHealth Market by Participants
11.5.1.6.3 Egypt mHealth Market by Services
11.5.1.7 Saudi Arabia
11.5.1.7.1 Saudi Arabia mHealth Market by Component
11.5.1.7.2 Saudi Arabia mHealth Market by Participants
11.5.1.7.3 Saudi Arabia mHealth Market by Services
11.5.1.8 Qatar
11.5.1.8.1 Qatar mHealth Market by Component
11.5.1.8.2 Qatar mHealth Market by Participants
11.5.1.8.3 Qatar mHealth Market by Services
11.5.1.9 Rest of Middle East
11.5.1.9.1 Rest of Middle East mHealth Market by Component
11.5.1.9.2 Rest of Middle East mHealth Market by Participants
11.5.1.9.3 Rest of Middle East mHealth Market by Services
11.5.2 Africa
11.5.2.1 Africa mHealth Market by Country
11.5.2.2 Africa mHealth Market by Component
11.5.2.3 Africa mHealth Market by Participants
11.5.2.4 Africa mHealth Market by Services
11.5.2.5 Nigeria
11.5.2.5.1 Nigeria mHealth Market by Component
11.5.2.5.2 Nigeria mHealth Market by Participants
11.5.2.5.3 Nigeria mHealth Market by Services
11.5.2.6 South Africa
11.5.2.6.1 South Africa mHealth Market by Component
11.5.2.6.2 South Africa mHealth Market by Participants
11.5.2.6.3 South Africa mHealth Market by Services
11.5.2.7 Rest of Africa
11.5.2.7.1 Rest of Africa mHealth Market by Component
11.5.2.7.2 Rest of Africa mHealth Market by Participants
11.5.2.7.3 Rest of Africa mHealth Market by Test type
11.6 Latin America
11.6.1 Latin America mHealth Market by country
11.6.2 Latin America mHealth Market by Component Type
11.6.3 Latin America mHealth Market by Technique
11.6.4 Latin America mHealth Market by Services
11.6.5 Brazil
11.6.5.1 Brazil America mHealth by Component Type
11.6.5.2 Brazil America mHealth by Technique
11.6.5.3 Brazil America mHealth by Services
11.6.6 Argentina
11.6.6.1 Argentina America mHealth by Component Type
11.6.6.2 Argentina America mHealth by Technique
11.6.6.3 Argentina America mHealth by Services
11.6.7 Colombia
11.6.7.1 Colombia America mHealth by Component Type
11.6.7.2 Colombia America mHealth by Technique
11.6.7.3 Colombia America mHealth by Services
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America mHealth by Component Type
11.6.8.2 Rest of Latin America mHealth by Technique
11.6.8.3 Rest of Latin America mHealth by Services
12. Company profile
12.1 AT &T
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 Telefonica
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Product/Services Offered
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 SoftServe
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Product/Services Offered
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Google
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Product/Services Offered
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Samsung Electronics
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Product/Services Offered
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Apple
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Product/Services Offered
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 Orange
12.7.1 Company Overview
12.7.2 Financials
12.7.3 Product/Services Offered
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8, mQure
12.8.1 Company Overview
12.8.2 Financials
12.8.3 Product/Services Offered
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Qualcomm Technologies,
12.9.1 Company Overview
12.9.2 Financials
12.9.3 Product/Services Offered
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 Vodafone Group
12.10.1 Company Overview
12.10.2 Financials
12.10.3 Product/Services Offered
12.10.4 SWOT Analysis
12.10.5 The SNS View
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions
14. Use Case and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Component
Wearables
mHealth Apps
By Participants
Mobile Participants
Device vendors
Content Players
Healthcare Providers
By Services
Monitoring Services
Diagnosis Services
Healthcare Systems
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Brain Tumor Drugs Market was estimated at US$ 2.9 billion in 2022 and is expected to reach US$ 5.73 billion by 2030 and is anticipated to increase at a CAGR of 8.9% predicted over the forecast period of 2022-2030.
The Oncology Drugs Market size was USD 221.38 Billion in 2023 and is expected to Reach USD 525.08 Billion by 2031 and grow at a CAGR of 11.4% over the forecast period of 2024-2031.
The Molecular Modeling Market Size was valued at USD 6.40 billion in 2023 and is expected to reach USD 19.47 billion by 2032 and grow at a CAGR of 13.18% over the forecast period 2024-2032.
Flash Chromatography Market was valued at USD 0.33 million in 2023, is projected to reach USD 0.50 million by 2032, growing at a CAGR of 4.6% from 2024 to 2032.
The Compounding Pharmacies Market Size was valued at USD 12.6 Billion in 2023 and will hit USD 19.9 Billion by 2032 with an emerging CAGR of 5.2% Over the Forecast Period of 2024-2032.
The Functional Service Providers (FSP) Market Size was valued at USD 14.68 billion in 2023, and is expected to reach USD 30.70 billion by 2032, and grow at a CAGR of 8.56% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
